← Eichor
Condition: Advanced Chronic Myeloid Leukemia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Advanced Chronic Myeloid Leukemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia
Phase 1 · 2 location(s) · Shenzhen TargetRx Co., Ltd. · NCT06088888Evaluation of Advanced Practice Nurse's Management of Patients With Chronic Myeloid Leukemia
NA · 1 location(s) · Centre Hospitalier Henri Duffaut - Avignon · NCT06082804Study to Evaluate the Safety and Tolerability of EP0042
Phase 1/Phase 2 · 6 location(s) · Ellipses Pharma · NCT04581512Quality of Life-Guided Transfusion in Refractory MDS or AML
NA · 1 location(s) · Centre Hospitalier Universitaire de Nice · NCT07328191(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Phase 2 · 42 location(s) · Cogent Biosciences, Inc. · NCT04996875Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia
Phase 2 · 4 location(s) · Theradex · NCT07033598Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, M
Phase 1/Phase 2 · 1 location(s) · Uma Borate · NCT06523556Unrelated Umbilical Cord Blood Stem Cell Combined With Azacitidine Based Treatment for Advanced MDS,CMML-2 and sAML
Phase 1/Phase 2 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT05584761A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
Phase 1 · 7 location(s) · Solu Therapeutics, Inc · NCT06950034A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Ph
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT06401603Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies
Phase 1 · 6 location(s) · Epigenetix, Inc. · NCT05488548
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.